Clinical utility of novel biomarkers in acute myocardial infarction

Medizin & Biologie

• Acute Coronary Syndrome 15%
• Acute Pain 5%
• Adiponectin 5%
• alpha-2-HS-Glycoprotein 7%
• Atrial Fibrillation 4%
• Biomarkers 85%
• Chest Pain 5%
• Clinical Decision-Making 11%
• copeptins 49%
• Coronary Artery Disease 4%
• Costs and Cost Analysis 6%
• Creatine Kinase 5%
• Decision Making 8%
• Echocardiography 4%
• Fibrosis 3%
• Galectin 3 6%
• Growth Differentiation Factor 15 16%
• Guidelines 6%
• Hemodynamics 11%
• Hypertension 3%
• Inflammation 6%
• Isoenzymes 5%
• Kidney Diseases 5%
• Kinetics 3%
• Left Ventricular Function 10%
• Magnetic Resonance Imaging 3%
• Magnetic Resonance Spectroscopy 4%
• MB Form Creatine Kinase 6%
• MicroRNAs 4%
• Mortality 2%
• Muscle Cells 4%
• Myocardial Infarction 95%
• Natriuretic Peptides 19%
• Necrosis 12%
• Non-ST Elevated Myocardial Infarction 34%
• Platelet Activation 5%
• Registries 4%
• Rupture 4%
• Sensitivity and Specificity 3%
• ST Elevation Myocardial Infarction 5%
• Systematic Reviews 3%
• Takotsubo Cardiomyopathy 7%
• Technology 3%
• Therapeutics 3%
• Troponin 100%
• Wounds and Injuries 10%